Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes

There are no files associated with this record.

Title Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes
Author McKeage, MarkJ.; Berners-Price, Sue; Galettis, Peter.; Bowen, Richard; Brouwer, Wandy.; Li, Ding.; Zhuang, Li.; Baguley, Bruce C.
Journal Name Cancer Chemotherapy and Pharmacology
Year Published 2000
Place of publication Germany
Publisher Springer-Verlag
Abstract Purpose: The lipophilic cation [Au(I)(dppe)2]+ [where dppe is 1,2-bis(diphenylphosphino)ethane] has previously demonstrated potent in vitro antitumour activity. We wished to determine the physicochemical basis for the cellular uptake of this drug, as well as of analogues including the 1:2 adducts of Au(I) with 1,2-bis(di-n-pyridylphosphino)ethane (dnpype; n=2, 3 and 4), and to compare in vitro and in vivo antitumour activity. Methods and results: Logarithmic IC50 values for the CH-1 cell line bore a parabolic dependence on drug lipophilicity, as measured either by high-performance liquid chromatography or by n-octanol-water partition. Cellular uptake of drug, as measured by inductively coupled plasma mass spectrometry, varied by over three orders of magnitude over the series. Logarithmic uptake had a parabolic dependence on drug lipophilicity but a linear relationship to logarithmic IC50 values. Free drug concentrations were determined under the culture conditions and logarithmic free drug IC50 values and uptake rates were linearly related to lipophilicity. Uptake of drug in vivo in tissue from murine colon 38 tumours was approximately proportional to the dose administered. Host toxicity varied according to lipophilicity with the most selective compound having an intermediate value. This compound was also the most active of those tested in vivo, giving a growth delay of 9 days following daily intraperitoneal dosing (10 days) at 4 μmol kg−1 day−1. It was also significantly more active than another lipophilic cation, MKT-077. Conclusions: Alteration of lipophilicity of aromatic cationic antitumour drugs greatly affects cellular uptake and binding to plasma proteins. Changes in lipophilicity also affect host toxicity, and optimal lipophilicity may be a critical factor in the design of analogues with high antitumour activity.
Peer Reviewed Yes
Published Yes
Alternative URI http://dx.doi.org/10.1007/s002800000166
Volume 46
Page from 343
Page to 350
ISSN 0344-5704
Date Accessioned 2001-01-01
Date Available 2010-07-26T06:51:56Z
Language en_AU
Research Centre Institute for Glycomics
Faculty Faculty of Science, Environment, Engineering and Technology
Subject PRE2009-Science & Technology
URI http://hdl.handle.net/10072/3244
Publication Type Article in Scholarly Refereed Journal
Publication Type Code c1

Show simple item record

Griffith University copyright notice